Warning
Novartis Pharmaceuticals Corporation Recalls Diovan (valsartan) 160 mg
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0746-2026Drug / Pharmaceutical
Novartis Pharmaceuticals Corporation Recalls Diovan (valsartan) 160 mg
Novartis Pharmaceuticals Corporation · Class II — Moderate Risk
Product Description
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Reason for Recall
Failed Dissolution Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Novartis Pharmaceuticals Corporation initiated the recall on August 4, 2026. Failed Dissolution Specifications. The product was distributed in US Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Novartis Pharmaceuticals Corporation for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.